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RE-EXPOSURE OF HUMAN LYMPHOBLASTOTD CELL LINES 
TO EPSTEIN-BARR VIRUS 
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Institut fur Virologie der Universitat, 8700 Wiirzburg, Versbacher Landstr. 7, West Germany 
Human lymphoblastoid lines of various origins which harbour Epstein-Burr virus 
(EBV)-specific nucleic acid were re-exposed to EBV. Following infection, cells of the 
non-virus-producing lines, Raji and S 95, predominantly synthesized EB V-specific early 
antigens ( E A ) ,  whereas only a small percentage of cells revealed viral capsid antigens 
( VCA). In Raji cells, the number of VCA-producing cells was paralleled by the 
percentage of virus-specific D NA-synthesizing cells. In S 95 cells, however, viral 
DNA-synthesizing cells exceeded the number of VCA-producing cells by a factor of 
more than 10. Induction of E A  in Raji cells was dose-dependent and inversely related 
to cell growth. Irradiation of the virus by ultraviolet light prior to infection led to 
reduced infectivity. This reduction seemed to follow single-hit kinetics. Raji cells, 
previously re-exposed to EBV, showed reduced EA induction after re-infection with 
EBV, as compared to Raji control cells not previously exposed. Of 10 lines which 
spontaneously synthesize EB V-specific antigens, seven lines proved to be refractory to 
re-infection, whereas three were as susceptible as the Raji and S 95 controls. From 
three of the refractory lines infectious virus could be recovered from the culture medium 
prior to infection. 
These results permit the following interpretations: ( I )  the response of human 
lymphoblastoid cells after re-infection with EB V results from the infecting virus and 
not from stimulation of endogenous genomes; ( 2 )  cells demonstrating EA synthesis 
ultimately die; (3 )  re-exposure to EBV increases the resistance to re-infection of the 
surviving cells; and ( 4 )  cell lines producing infectious EBVare refractory to re-infection. 
It is suggested that the spontaneous synthesis of infectious virus favours the selection of 
resistant cells. 
Epstein-Barr virus (EBV) specific antigens have 
been observed in all human lymphoblastoid cell 
lines which were carefully examined for their 
presence (reviewed by Epstein, 1970; Klein, 1972; 
zur Hausen, 1972). Usually a small number of 
cells synthesize EBV, whereby the rate of virus 
production seems to be cell-line-specific. Cloning 
experiments (Zajac and Kohn, 1970; Maurer et 
al., 1970), induction of  viral particle synthesis by 
chemical inducers (Hampar et al., 1972; Gerber, 
1972), and nucleic acid hybridization experiments 
(zur Hausen and Schulte-Holthausen, 1970; 
Nonoyama and Pagano, 1971 ; zur Hausen et al., 
19726) revealed that every one of these cells 
carries the viral genetic information. There exists 
also some evidence that uptake of viral genomes 
is a prerequisite for their continuous proliferation 
in tissue culture (Pope et al., 1968; Nilsson et al., 
1971; Chang et al., 1971). Transformation of 
human lymphocytes in vitro is quite easily 
achieved by infecting these cells with EBV (Henle 
et al., 1967; Pope et al., 1968; Chang et al., 1971). 
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Despite a number of efforts, however, EBV 
cannot be grown in primary human or animal 
cells. Neither epithelial nor fibroblastic cells 
proved to be susceptible for this agent and 
attempts to produce virus in primary human 
leukocytes were also unsuccessful. Since a 
relationship of this virus to infectious mono- 
nucleosis has been postulated (Henle et a/., 1968; 
Niederman et a/., 1968), still undiscovered 
permissive cells (permissive for virus production) 
must exist in order to guarantee the continuous 
transfer of viral infections. 
In recent years it has been shown that some 
lymphoblastoid cell lines of human origin which 
already harbour EB viral genomes (reviewed by 
zur Hausen, 1972) are susceptible to re-infection 
by EBV (Horosciewicz et a/., 1970; Durr et al., 
1970; Pearson et al., 1970). These cells, although 
probably previously transformed by the same 
virus, represent at the present time the only 
subject for studying the time course of EB viral 
macromolecule synthesis in lytic infections. Most 
of these cells become abortively infected: they 
synthesize EBV-specific antigens without viral 
particle production (Henle et al., 1970; Henle et 
al., 1971). The susceptibility of cells from lym- 
phoblastoid lines to re-infection varies from line 
to line. This seems to depend in part on the 
presence or absence of virus-specific receptors on 
the cell membrane (Klein et a/., personal com- 
munication). 
The following report tries to analyze some of 
the aspects of re-infection of selected lympho- 
blastoid cell lines by EBV. Special attention is 
focused on the question whether the alterations 
of the host cells, induced upon re-exposure, are 
due to stimulation of endogenous or to newly 
penetrated viral genomes. The synthesis of viral 
DNA in the abortive cycle, as well as the re- 
infectibility of EBV-synthesizing cells, in com- 
parison to cells of non-virus-producing lympho- 
blastoid lines, are also examined. 
MATERIAL AND METHODS 
Cell lines 
The origin of cell lines used in these experiments 
is summarized in Table I. The Table also contains 
the percentage of cells which reveal EBV- 
specified antigens as detected by immunofluor- 
escence. The cells were maintained in medium 
RPMI 1629 supplemented with 10 or 20% foetal 
bovine serum, penicillin and streptomycin (Diehl 
et a/., 1968). 
EB V preparations 
EBV was obtained from P3HR-I cells by two 
procedures: (1) 700 ml of supernatants from 
P3HR-1 cells (1.5-2.2 x lo6 cells/ml), grown for 
10-12 days at 34” C, were clarified by low-speed 
centrifugation (10 min, 1,000 xg). This was 
followed by centrifugation at 45,000 xg over a 
TABLE I 
ORIGIN OF CELL LINES AND PRESENCE OF EBV-SPECIFIC ANTIGENS WITHIN THEIR CELLS 
EBV-reactivity percent 
fluorescent cells 
EAandVCA VCA 
Cell line Origin References 
P3HR-I Burkitt’s lymphoma-clone of P3J Hinuma et al. (1967) 7.5 % 4.5 % 
HK LY-28 Nasopharyngeal carcinoma (tumor) de The er al. (1969) 1.6% 0.4 % 
Kaplan Infect. mononucleosis (per. blood) Diehl et a/. (1968) 1.75 0.6 % 
Di 1 Healthy individual (per. blood) Diehl, unpublished results 10.7 % 9.6 ”/, 
Di I 1  Healthy individual (per. blood) Diehl, unpublished results 1.8% 0.5 % 
Di 1V Healthy individual (per. blood) Diehl, unpublished results 0.6% 0.4 % 
Di V Healthy individual (per. blood) Diehl, unpublished results 0.6 % 0.4 % 
Raji Burkitt’s lymphoma (tumor) Pulvertaft (1 964) <0.001% <0.001% 
S-95 Hodgkin’s disease, sarcoma type Diehl and Johansson, in <<0.001 % 10.001 % 
SI I8 Hodgkin’s disease, grand. type Diehl and Johansson, in 0.5 ”/, 0.1 % 
2003 (P,J) Burkitt’s lymphoma (tumor) Pulvertaft, unpublished results 0.1 % 0.1 % 
(pleural effusion) preparation 
(per. blood) preparation 
SHO I Healthy individual (per. blood) Diehl, unpublished results 4.5 % 2.5 % 
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period of 110 min in the 21 rotor of the Beckman 
preparative centrifuge. The resulting sediment 
was resuspended in a small volume in order to 
obtain a 30- to 70-fold concentrate. The PH of 
these preparations was adjusted to 7.0. They 
were stored at 4" C until used. Concentrates 
could be kept at this temperature up to 17 days 
without detectable loss of infectious EBV. 
(2) Supernatants of P3HR-1 cells, kept for 
6-8 days in the same medium, were clarified by 
two centrifugations at 1,000 x g  for 10 min each. 
The supernatants were carefully removed with a 
Pasteur pipette, their PH was adjusted and they 
were stored at 4" C until used. 
In addition to P3HR-1 cells, concentration of 
EBV was attempted from five other EBV- 
producing cell lines (Di-I, Di-11, Kaplan, HK 
LY-28, S118). Supernatants from a non-virus- 
producing line (Raji) were concentrated in the 
same way and used as controls. 
Infectivity tests 
Infectivity was assayed by infecting 3 x lo6 cells 
with 1 ml of the virus suspension. The virus was 
allowed to absorb for 2 h at 37" C. Thereafter, 
8 ml of fresh culture medium were added. After 
additional incubation for 48 and 72 h at 37" C, 
the cells were acetone-fixed and examined for 
EBV-specific antigen production by direct immu- 
nofluorescence. 
Immunofluorescence tests 
Infected cells were monitored for induction of 
EBV-associated capsid (VCA) and early antigens 
(EA) by methods described by Henle et al. 
(Henle and Henle, 1966; Henle et al., 1970). For 
VCA tests, fluorescein-isothiocyanate (FITC) 
conjugated human serum (anti-VCA titre 1 :640), 
derived from a healthy individual, was used in a 
dilution of 1:30. At this concentration no 
reactivity against EA could be detected. 
A FITC-conjugated serum from a patient with 
Burkitt's lymphoma '' Nathan " was kindly 
supplied by Dr. George Klein (Karolinska 
Institutet, Stockholm), and used for the detection 
of EA in a dilution of 1 :20-30. The difference in 
fluorescence-positive cells, resulting from the 
separate incubation of infected cells with both 
sera, indicated the EA reactivity. 
Cell counting 
The number of viable cells was determined by 
trypan-blue exclusion tests in the Neubauer 
haematocytometer chamber. 
Irradiation of EBV by ultraviolet light (U V )  
Five ml of the virus suspension (in RPMI 1629 
with 10% calf serum in a 6 cm Petri dish) were 
UV-irradiated (Thomas UV-lamp) at a distance 
of 10cm for different periods of time, during 
which they were continuously stirred with a 
magnetic stirrer. 
Membrane and in situ hybridizations 
The techniques used for membrane and in situ 
hybridizations have been described before (zur 
Hausen and Schulte-Holthausen, 1970; zur 
Hausen and Schulte-Holthausen, 1972~). EBV- 
specific complementary RNA (cRNA), of high 
specific radioactivity (about 2 x lo7 cpm/,ug) syn- 
thesized in vitro with the aid of E. coli RNA 
polymerase, was used for all tests. 
RESULTS 
Induction of EB V-associated antigens and virus- 
specific D N A  synthesis in Raji and S 95 cells 
After infection of Raji cells with concentrated 
EBV, derived from P3HR-1 supernatants, the 
time course of virus-specific macromolecule 
synthesis was studied. After various periods post 
infection, cells were removed for immunofluor- 
escence and in situ hybridizations. In addition, 
DNA was extracted for filter hybridization with 
EBV-cRNA. The results are shown in Figure 1.  
EBV-specific early antigens appeared first 
about 12 h after infection, as previously described 
by others (Henle et al., 1970; Gergely et al., 1971 ; 
Horosciewicz et al., 1970). The number of 
fluorescent cells increased up to 72 h PI. There- 
after it rapidly declined, and only an occasional 
cell was still found to be positive for EA 30 days 
after infection. VCA was first detected about 
24 h after exposure to EBV but only in a small 
number of cells (1.5%). After 6 additional days 
no VCA synthesis was discernible. 
The number of VCA-synthesizing cells was 
paralleled by the counts of labelled nuclei after 
in situ hybridizations. Thus, EBV-DNA synthesis 
after re-infection of Raji cells was correlated to 
VCA production. Additional confirmation for 
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FIGURE 1 
Induction of EBV-specific antigens and viral DNA synthesis after infection 
of Raji cells with EBV. Early antigen synthesis (0-0) starts after about 
12 h and reaches a peak about 72 h post infection. Only a small number of 
cells demonstrate VCA production (..-=-.). Approximately the same number 
of cells synthesize viral DNA (0-0), as shown by in situ hybridization 
with EBV-cRNA. A significant increase of virus-specific DNA synthesis after 
infection with EBV is also indicated by hybridization on nitrocellulose filters 
of DNA derived from infected cells after various periods of infection with 
EBV-cRNA (..DD.). 
virus-specific DNA synthesis originated from 
membrane hybridizations. Hybridizability of Raji 
DNA with EBV-cRNA increased approximately 
15-fold about 40 h post infection. 
In S 95 cells, infection with EBV concentrates 
provoked a similar response as far as EA and 
VCA synthesis were concerned (Fig. 2). The 
decline in EA synthesis after 3 days PI, however, 
was slower than in Raji cells. Despite a low 
percentage of VCA-synthesizing cells (1.8 % 
48 h after infection), there was a surprisingly 
high number of EBV-DNA producing cells as 
revealed by in situ hybridizations (Fig. 3). Three 
days after infection they exceeded the counts for 
VCA-positive cells 22-fold, approaching the 
number of EA-reactive cells. This increased 
EBV-DNA production in S 95 cells as compared 
to Raji cells was also indicated by an approxi- 
mately 30-fold increase in hybridization with 
EBV-cRNA 40 h after infection as compared to 
values of uninfected S 95 cells. The discrepancy 
in the number of VCA-producing and EBV 
DNA-synthesizing cells after EBV-re-infection 
was repeatedly observed in this line and remains 
as yet unexplained. 
Dose-response after re-exposure of Raji and S 95 
cells to EBV 
Induction of EBV-specified antigens (EA and 
VCA), as well as survival of the infected cells, 
was studied in Raji and S 95 cells by the use of 
different dilutions of EBV concentrates for 
infection. The resuIt is shown in Table 11. 
This Table demonstrates that EBV antigen 
reactivity was inversely related to cell survival. 
When non-diluted viral concentrates were used 
as input, only a fraction of the original cell 
population was still alive 72 h after infection. 
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FIGURE 2 
D a y s  
Induction of EBV-specific antigens and viral DNA synthesis after infection 
of S 95 cells with EBV. The increase in early antigen synthesis (0-0) is 
paralleled by an increase in viral DNA synthesis, as revealed by in situ 
hybridizations (0-0) and hybridization on nitrocellulose filters (q H m.). 
Only a small number of cells produce EBV-VCA (-D-w.). 
This indicated that the abortive infection of Raji 
and S 95 cells resulted in killing of the cells. 
Apparently induction of early antigens without 
viral DNA synthesis (at least in the case of Raji 
cells) led to cell destruction and death. 
Although the data shown in Table I1 did not 
reveal a linear decrease in the number of fluor- 
escent cells after infection with various dilutions 
of EBV-concentrates, they indicated the depen- 
dence of virus-specific antigen synthesis on the 
multiplicity of infection. A similar dependence on 
the EBV-input for virus-specific antigen synthesis 
and cell survival, as indicated in Table 11, has 
been observed 48 and 96 h after infection. 
UV-irradiation reduced the number of viral 
antigen-synthesizing cells corresponding to the 
time of exposure. Whereas 28.5% of the cells 
showed viral antigens 72 h after infection with 
non-irradiated virus, almost no specific fluor- 
escence was detectable after 8 min of irradiation 
prior to infection. Here again cell survival was 
inversely related to the dose of infectious virus. 
The decrease in the induction of virus-specific 
immunofluorescence after UV-irradiation of the 
virus seems to follow single-hit kinetics. 
Re-exposure of EBV re-infected cells to EBV 
To determine whether Raji cells surviving 
infection with EBV-concentrates remain suscep- 
tible to EBV, these cells were re-exDosed to the 
EB V-speciJc antigens afrer infection of Raji cells 
with UV-irradiated virus 
Raji cells were exposed to EBV, irradiated for 
various periods prior to infection. A representa- 
tive experiment is shown in Figure 4. 
virus 33 and 75 days after the first infection. 
Uninfected Raji cells served as controls. The 
result is shown in Figure 5. 
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FIGURE 3 
heavily labelled nuclei in contrast to some almost unlabelled cells. 
In situ hybridization of 3H-labelled EBV-cRNA with S 95 cells 72 h after infection with EBV. Note the 
The pre-infected Raji cells were less susceptible 
t o  re-infection. This was especially pronounced 
in the Raji line which had been infected 75 days 
earlier. 
By annealing DNA from both pre-exposed 
Raji lines with EBV-cRNA, these hybridized 
slightly above the values of D N A  from non- 
infected Kaji cells (1.32 and 1.38 times more 
than the controls). This could suggest that 
exposure of Raji cells to  EBV increased the viral 
genome content of the surviving cells. 
Re-infection of cells from EB virus-synthesizing 
lines with EBV 
Cells of EBV-synthesizing lymphoblastoid lines 
were infected with EBV concentrates. Raji and 
S 95 cells served as controls. Figure 6 shows the 
E A  and VCA synthesis in five recently isolated 
virus-synthesizing lines after infection with EBV. 
Four of these lines (Di-11, Di-IV, Di-V, and 
SHO, all derived from healthy donors) did not 
show any increase in virus-specific antigen 
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TABLE 11 
tNDUCTLON OF EBV-ASSOCIATED ANTCGENS 72 H 
WLTH VARIOUS CONCENTRATIONS OF EBV 
AFTER INFECTION OF RAJI AND S 95 CELLS 
Raji 
s 95 
non-dil. 
I :3 
I :9 
1 :27 
no virus 
non-dil. 
1 :3 
I :9 
1 :27 
no virus 
45 
36 
14 
10 
0 
25 
21 
9 
6 
0 
0.05 
0.14 
0.29 
0.65 
1.31 
0.10 
0.2 I 
0.25 
0.34 
0.59 
100 
10 
m - 
P) 
U l  
Y 
C 
U 
u) : 
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2 
2 
Y 
u 
0.01 
Time of UV- irradiation in minutes 
FIGURE 4
Induction of early antigens in Raji cells after 
infection with EBV irradiated for various periods by 
ultraviolet light. 
Time in hours 
FIGURE 5 
Re-exposure of EBV re-infected cells to EBV 33 
(o......o) and 75 days (0-0) after the first 
exposure to EBV. (.---.) represents the control 
which was not pre-exposed to EBV. 
synthesis. The fifth one, however, S 118, derived 
from the peripheral blood of a patient with 
Hodgkin's disease, was as sensitive to re- 
infection as Raji and S 95 cells. 
Following infection of cells of five additional 
virus-producing lines, most of which had been 
in culture for several years, three of these 
(P3HR-1, 2003, and Di-I) proved to be refractory 
to re-infection (Fig. 7). The other two, Kaplan 
and HKLY-28, however, showed a considerable 
increase in early antigen synthesis. To a lesser 
extent, an increase in viral capsid antigen positive 
cells was also noted in these two lines. 
Recovery of infectious virus from virus-producing 
cell lines 
Supernatants of cells from six EB virus VCA- 
synthesizing lines were concentrated one hundred 
fold and used for infection of Raji cells. The 
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FIGURE 6 
Induction of early antigen synthesis in various cell 
lines after infection with EBV. Except for the Raji 
control, all other lines represent recent isolates. 
induction of EA in these cells after various 
periods of infection is shown in Table 111. The 
two lines with a rather high VCA-reactivity 
(P3HR-1 and Di-I) induced EA synthesis in Raji 
cells 72 h post infection in 30.1 and 22.4% 
respectively. A third line which was also refrac- 
tory to re-infection, Di-11, induced virus-specific 
antigens in a very small percentage of cells. 
Concentrates derived from the three VCA- 
producing lines which were susceptible to re- 
infection (HKLY-28, Kaplan, and S 118), did 
not induce detectable amounts of EBV-specific 
antigens after infection of Raji cells. 
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FIGURE 7
Induction of early antigen synthesis, in various cell 
lines after infection with EBV. Except for the Di-I 
line, all other lines have been kept in tissue culture 
for several years. 
TABLE 111 
INFECTION OF RAJI CELLS WITH 100 FOLD 
CONCENTRATES OF VARIOUS VIRUS PRODUCING 
CELL LINES 
Percent VCA and EA positive 
48 h 12 h 9 6 h  
Virus- Percent VCA cells after 
donor lines reactivity 
HRlK 5.3 29.9 30.1 19.7 
Di-I 8.4 20.2 22.4 22.1 
Di-I1 0.3 0.02 0.01 0 
Ly-28 0.4 0.01(?) 0 0 
Kadan 0.5 0 0 0 
S118 0.2 0 0 0 
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DISCUSSION 
Infection of primary human lymphocytes with 
EBV results in the establishment of lymphoblas- 
toid cell lines (Henle et a/., 1967; Diehl et a/., 
1968; Pope et al., 1968; Nilsson et al., 1971; 
Miller et al., 1970; Chang et a/., 1971). Usually 
a small percentage of these continuously proli- 
ferating cells is induced to synthesize EBV which 
leads to death of the involved cell. No lytic 
response, however, has been observed thus far 
after exposure of primary cells to EBV. 
It is therefore rather surprising that cells of 
several transformed lines which contain a con- 
siderable load of persisting EBV genomes (zur 
Hausen and Schulte-Holthausen, 1970; Nono- 
yama and Pagano, 1971; zur Hausen and 
Schulte-Holthausen, 19726; zur Hausen et al., 
1972) react upon re-exposure to EBV with virus- 
specific antigen synthesis and cell death. In this 
study, the two non-virus-producing lymphoblas- 
toid cell lines, Raji and S 95, proved to be 
susceptible to re-infection. At least in the majority 
of the infected cells virus replication was abortive: 
in Raji cells, early antigen synthesis was pre- 
dominant. Only a small number of cells revealed 
viral DNA and VCA production. In S 95 cells, 
a similar situation was encountered, except for a 
much higher number of viral DNA-synthesizing 
cells. Thus far it is not understood why in this 
case the number of viral structural antigen 
producing cells, as visualized by immunofluor- 
escence, did not correspond to the number of 
viral DNA-replicating cells. In both lines, 
abortive infection resulted in death of the 
affected cells. 
The described reaction of EBV genome- 
carrying lines to EBV re-infection could be 
explained by two alternatives: either the infecting 
genome is responsible for the synthesis of EBV- 
specific proteins and DNA, or a virus-specific 
product, transferred to the recipient cell during 
infection, derepresses and stimulates the endo- 
genous genomes. Our experiments provide 
evidence for the first alternative, since UV- 
inactivation kinetics point to a direct involvement 
of the genome of the infecting virus. It is possible 
that the endogenous EBV genomes in Raji and 
S 95 cells cannot be reactivated under these 
conditions due to genomic defects-this in spite 
of the recent demonstration that Raji cells 
contain viral DNA of the size of complete 
genomes (Nonoyama and Pagano, 1972). The 
reactivation of these genomes after 5-bromo- 
deoxyuridine (BUdR) treatment (Hampar et ul., 
1972; Gerber, 1972) could be explained by 
assuming reverting point mutations due to 
BUdR incorporation. 
The response of cells from EBV-synthesizing 
lines to EBV re-exposure varies from line to line. 
Whereas seven lines tested in this study proved 
to be refractory to re-infection, three others were 
almost as susceptible as the Raji and S95 
controls. In these experiments we did not test 
whether resistance to re-infection, as observed in 
the majority of virus-synthesizing lines, was due 
to lack of viral adsorption or to an effect on 
penetration and uncoating of the virus. It has 
been shown by Klein et al., 1972 (personal 
communication), however, that some of the 
resistant lines do not adsorb virus whereas in 
others viral adsorption was not inhibited at all. 
Since we have been able to isolate infectious 
virus only from three lines which were resistant 
to re-infection, these data suggest that resistance 
to re-infection and infectious virus synthesis might 
be correlated. It is tempting to speculate that 
spontaneous induction of infectious virus must 
result in the selection of cells which are resistant 
to re-infection with their own virus. The inhibi- 
tion of the infectious process could occur at 
various levels before irreparable damage alters 
the host cell. 
This interpretation is supported by the re- 
infection experiments of Raji cells which survived 
a previous EBV re-exposure. These cells were 
more resistant to EBV as compared to the 
non-exposed control culture. 
The abortive response of persistently EBV- 
infected human lymphoblastoid lines to re- 
infection, in addition to the non-lytic infection of 
primary lymphocytes, clearly indicates that the 
postulated permissive cells which guarantee the 
continuous transfer of EBV infections, still 
remain to be discovered. 
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REEXPOSITION DES LlGNEES CELLULAIRES LY MPHOBLASTOIDES 
HUMATNES AU VIRUS D’EPSTEIN-BARR 
Des lignkes lymphoblasto fdes hurnaines d’origines diverses, qui contiennent de 
I’acide nuclkique spkcifique du virus d’Epstein-Barr ( VEB) , ont ktk rkexposkes au 
VEB. Apr& I’infrction, les cellules des lignies Raji et S 95, qui ne produisairnt pas de 
viru.5, ont surtout synthktisk des antigtnes prkcoces ( E A )  spkcifiques du VEB, alors 
qu’un faible pourcentage de cellules contenait des antigenes des capsides virales ( VCA)  . 
Dans les cellules Raji, on a observt un parallklisme entre le nombre de cellules produc- 
trices cle VCA et le pourcentage de cellules synthktisant I‘ADN spkcifique du virus. 
Par contre, dans les cellules S 95, les cellules synthetisant I’ADN viral gtaient au rnoins 
dix fois plus nombreuses que les cellules produisant des VCA. L’introduction d’EA dans 
les cellules Raji dkpendait de la dose et etait inversement proportionnelfe a fa  croissance 
cellulaire. L’irradiation da virus par les ultraviolets avant l’infection rkduit le pouvoir 
infectieux. Ce phknomkne semble relever d’une cinktique ‘‘ a uti coup ”. Les cellules 
Raji, prkalablement reexposgees au VEB, induisent rnoins d’EA apr& la reinfection par 
le VEB que les crllules tkmoins Raji qui n’ont pas dkja et t  exposkes au virus. Lors de la 
rkinfection des cellules provenant de dix lignkes qui synthitisent spontanement les anti- 
gPnes spPcij5ques du VEB, sept IignPes se sont avkrges rejractaires, alors que trois 
ligneeJ ktaient aussi sensibles que les tkmoins Raji et S 95. Dans trois lignkes rkfrac- 
taires, on a rkcupert du virus infectieux dans le milieu de culture avant I’infection. 
Ces rksultats perrnettent de jormuler les interpretations suivantes: I )  la rkponse 
des cellules lymphoblastoi‘des humaines apres la rkinfection par le VEB provient du 
virus itlfectant et non d’une stimulation des gknomes endogenes; 2 )  les cellules qui 
synthgtisent fes EA finissent par mourir; 3 j la rtexposition au VEB accro-oit f a  rksis- 
tance a la rkinfection des cellules survivantes; et 4 )  les ligntes cellulaires produisant 
du VEB injectieux sont rkfractaires d la rkinfection. Les auteurs pensent que fa  synthsse 
spontanke du virus infectieux favorise la sklection des cellules rksistantes. 
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